Prosecution Insights
Prosecution Insights
Technology area: Medical Devices & Mechanical Engineering
3 pending office actions • 2 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
The Secant Group LLC currently faces 3 pending office actions within the Medical Devices & Mechanical Engineering technology area. These actions are distributed among 3 distinct examiners, indicating a varied prosecution front. Despite the number of examiners, the work is concentrated within 2 distinct art units, which suggests that the underlying technologies share significant commonalities or fall under similar classification groups. This concentration in 2 art units may allow for some overlap in prosecution strategy. The applicant can benefit from analyzing the shared standards of these 2 distinct art units to streamline their responses.
Examiner FLORES, ADRIAN is the busiest examiner for the portfolio with 1 pending office action. With 3 distinct examiners each handling 1 of the 3 pending actions, the workload is evenly split across the individual reviewers. This arrangement means that the applicant must manage 3 separate examiner relationships while navigating the specific nuances of the 2 art units involved in the review process. Practitioners should look for trends within these 2 art units to better predict examiner behavior. Resolving the 1 pending office action with the busiest examiner will be a key step in managing the 3 pending office actions currently on file.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (67%) |
| Multi-statute (no §101) | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| FLORES, ADRIAN | 1 | 100.0% | +0.0% |
| STEWART, ALVIN J | 1 | 82.1% | +0.7% |
| WHITE, KIA XIONG | 1 | 66.0% | +44.1% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18445111 | Suture-free stent grafts and stent graft constructs with integrated extensions and methods for forming | FLORES, ADRIAN | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17937633 | INTEGRALLY WOVEN MANIFOLDS AND METHODS FOR FORMING | STEWART, ALVIN J | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17646960 | POLY(GLYCEROL SEBACATE) URETHANE ELASTOMERIC LEAFLET FOR HEART VALVE REPLACEMENT | WHITE, KIA XIONG | — |
| Art Unit | Apps |
|---|---|
| 3774 | 2 |
| 3799 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18445111 | Suture-free stent grafts and stent graft constructs with integrated extensions and methods for forming | FLORES, ADRIAN | 3774 | §103 | Final Rejection | — | Pending | Apr 11, 2023 |
| 17937633 | INTEGRALLY WOVEN MANIFOLDS AND METHODS FOR FORMING | STEWART, ALVIN J | 3799 | §102§103 | Non-Final OA | — | Pending | Oct 03, 2022 |
| 17646960 | POLY(GLYCEROL SEBACATE) URETHANE ELASTOMERIC LEAFLET FOR HEART VALVE REPLACEMENT | WHITE, KIA XIONG | 3774 | §103 | Final Rejection | — | Pending | Jan 04, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial